Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis. [electronic resource]
- Internal medicine (Tokyo, Japan) Aug 2020
- 1849-1853 p. digital
Publication Type: Case Reports; Journal Article
1349-7235
10.2169/internalmedicine.4593-20 doi
Aged Amino Acids, Branched-Chain--adverse effects Anti-Bacterial Agents--therapeutic use Blind Loop Syndrome--chemically induced Breath Tests--methods Hepatic Encephalopathy--drug therapy Humans Lactulose--adverse effects Liver Cirrhosis, Alcoholic--complications Male Rifaximin--therapeutic use